Home > Boards > US Listed > Medical - Healthcare > Orasure Technologies (OSUR)

Ticker keeps hitting new highs and is in

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
HokieHead Member Profile
Member Level 
Followed By 820
Posts 52,557
Boards Moderated 6
Alias Born 09/30/04
160x600 placeholder
OraSure Technologies Announces 2021 Annual Meeting Date GlobeNewswire Inc. - 1/8/2021 6:00:00 AM
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/5/2021 6:00:00 AM
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test GlobeNewswire Inc. - 12/23/2020 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 4:46:28 PM
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 ... GlobeNewswire Inc. - 12/21/2020 4:01:00 PM
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell GlobeNewswire Inc. - 11/30/2020 7:00:00 AM
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/30/2020 7:00:00 AM
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 GlobeNewswire Inc. - 11/12/2020 7:00:00 AM
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Co... PR Newswire (US) - 11/9/2020 8:02:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:58:40 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:21:49 PM
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments GlobeNewswire Inc. - 11/4/2020 4:01:00 PM
OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Devic... GlobeNewswire Inc. - 11/3/2020 7:00:00 AM
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET GlobeNewswire Inc. - 10/21/2020 6:00:10 AM
OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 GlobeNewswire Inc. - 10/19/2020 6:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/28/2020 4:59:05 PM
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test GlobeNewswire Inc. - 9/24/2020 6:00:10 AM
Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific... GlobeNewswire Inc. - 9/15/2020 12:00:10 PM
Correction to Rapid Covid-19 Tests Article (Sept. 8) Dow Jones News - 9/9/2020 1:02:00 PM
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test GlobeNewswire Inc. - 9/3/2020 4:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 6:00:36 AM
OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 8/27/2020 4:30:10 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/26/2020 4:31:44 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/10/2020 4:59:30 PM
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs GlobeNewswire Inc. - 8/5/2020 4:01:10 PM
HokieHead Member Level  Wednesday, 04/15/20 03:32:23 PM
Re: None
Post # of 366 
Ticker keeps hitting new highs and is in the rapid testing via saliva CV-19 testing. Looks like a winner from here imo. FDA approval for in-home test news any day now imo.

-The diagnostic test company said it plans to file for FDA Emergency Use Authorization allowing for an in-home self-test to debut into the U.S. market.

-OraSure said its portable rapid test platform uses an oral fluid sample and provides results in 20 minutes, with no instrumentation or trained personnel needed to administer the test or read the results.

-Co announced it has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS), to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples. This support from BARDA will enable OraSure to file for FDA Emergency Use Authorization (EUA) allowing for an in-home self-test to debut into the U.S. market.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences